Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.

Melanoma research - 1 Aug 2010

Nielsen Kari, Harbst Katja, Måsbäck Anna, Jönsson Göran, Borg Ake, Olsson Håkan, Ingvar Christian

Abstract excerpt

Phenotypic characteristics were examined in melanoma-prone southern Swedish CDKN2A (p16-113insArg/p14ARF-128insSer) mutation families, in relation to the CDKN2A genotype, nevi, clinically atypical nevi (CAN) and melanoma. Individuals from eight melanoma-prone families, with index patients carrying the CDKN2A mutation, were offered skin examinations and genotyping (CDKN2A and MC1R). Ninety-three individuals above...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclin-Dependent Kinase Inhibitor p16
Share to Dysplastic Nevus Syndrome

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Germ-Line Mutation

Share to Melanoma

Share to Phenotype

Share to Skin Neoplasms

Share to Sweden

Source

Identifiers

PMID: 20526219
DOI: 10.1097/CMR.0b013e3283341339

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.PMID 20526219Read ↗

Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy.Semantic proximity Read ↗

Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study.Semantic proximity Read ↗

FAMMM syndrome: pathogenesis and management.Semantic proximity Read ↗

Familial atypical multiple mole melanoma (FAMMM) syndrome: history, genetics, and heterogeneity.Semantic proximity Read ↗

CDKN2A Gene Mutations: Implications for Hereditary Cancer SyndromesSemantic proximity Read ↗

Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants.Semantic proximity Read ↗

Characteristics of Familial Melanoma in Valencia, Spain, Based on the Presence of CDKN2A Mutations and MC1R Variants.Semantic proximity Read ↗

Familial melanoma.Semantic proximity Read ↗

How common is the atypical mole syndrome phenotype in apparently sporadic melanoma?Semantic proximity Read ↗

Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations.Semantic proximity Read ↗

CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families.Semantic proximity Read ↗

CDKN2A mutations with p14 loss predisposing to multiple nerve sheath tumours, melanoma, dysplastic naevi and internal malignancies: a case series and review of the literature.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.